Rallybio (RLYB) Assets (2020 - 2026)
Rallybio (RLYB) posted Assets of $54.5 million for Q1 2026, down 12.51% sequentially from $62.3 million in Q4 2025, and down 6.06% YoY from $58.0 million in Q1 2025.
Rallybio (RLYB) Assets (2020 - 2026) Analysis & Trends
Rallybio has reported Assets for 7 years, with the latest figure at $54.5 million in Q1 2026.
- Quarterly Assets fell 6.06% year-over-year to $54.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.5 million (down 6.06% YoY) and the FY2025 annual result came in at $62.3 million, down 8.58% from the prior year.
- Assets slipped to $54.5 million in Q1 2026 per RLYB's latest filing, from $62.3 million in the prior quarter.
- Over five years, Assets peaked at $180.4 million in Q4 2022 and troughed at $51.0 million in Q2 2025.
- A 5-year average of $108.2 million and a median of $99.4 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets grew 29.57% in 2022, then slumped 44.82% in 2025.
- Over 5 years, Assets stood at $180.4 million in 2022, then sank by 35.92% to $115.6 million in 2023, then plunged by 41.09% to $68.1 million in 2024, then decreased by 8.58% to $62.3 million in 2025, then decreased by 12.51% to $54.5 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $54.5 million, $62.3 million, and $67.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 19.82 Bn |
| 10 | Rallybio | 94.78 Mn | 94.78 Mn | - | 98.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 98.06 Mn |
| Mar 31, 2026 | 54.47 Mn |
| Dec 31, 2025 | 62.26 Mn |
| Sep 30, 2025 | 67.66 Mn |
| Jun 30, 2025 | 51.00 Mn |
| Mar 31, 2025 | 57.98 Mn |
| Dec 31, 2024 | 68.11 Mn |
| Sep 30, 2024 | 79.01 Mn |
| Jun 30, 2024 | 92.43 Mn |
| Mar 31, 2024 | 99.36 Mn |
| Dec 31, 2023 | 115.62 Mn |
| Sep 30, 2023 | 133.19 Mn |
| Jun 30, 2023 | 147.58 Mn |
| Mar 31, 2023 | 162.32 Mn |
| Dec 31, 2022 | 180.44 Mn |
| Sep 30, 2022 | 143.67 Mn |
| Jun 30, 2022 | 155.61 Mn |
| Mar 31, 2022 | 169.35 Mn |
| Dec 31, 2021 | 182.19 Mn |
| Sep 30, 2021 | 193.87 Mn |